Pharmacists in Washington, MO Accepting Medicare

28 Pharmacists found. Showing 21 - 28

William Rall Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1701 A Roy Dr, Washington, MO 63090 Phone: 636-239-3710

Dr. Clarissa E Hall, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3021 Highway A, Suite 203, Washington, MO 63090 Phone: 636-390-2828    Fax: 636-390-2598

Wade Weibrecht, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 890 Washington Cors, Washington, MO 63090 Phone: 636-239-7483

Dr. Melissa Elizabeth Liesmann, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1701 A Roy Dr, Washington, MO 63090 Phone: 636-239-3710

Jessica Kathleen Brinkmeyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8777

Mrs. Julie Joanne Lynch, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 890 Country Corners, Washington, MO 63090 Phone: 636-239-7483

Kerri Koleen Nichols, DOCTORATE PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1851 Vernaci Dr, Washington, MO 63090 Phone: 368-257-7016

Jennifer Biermann, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 801 E 5th Street, Washington, MO 63090 Phone: 636-239-8777

News Archive

Changing the underlying structure and culture of a clinic to address opioid epidemic

For the 20 percent of Americans who suffer from chronic pain, prescription opioids may bring relief, but also risks. An estimated 21 to 29 percent of patients who receive chronic opioid treatment will misuse their medications, and 8 to 12 percent will develop an opioid use disorder.

GORE DrySeal Sheath with hydrophilic coating now available in Europe

W. L. Gore & Associates (Gore) today introduced GORE DrySeal Sheath with hydrophilic coating in Europe. The new GORE DrySeal Sheath allows for easier insertion into and removal from blood vessels during endovascular repair procedures.

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

Almac establishes regional hubs in Singapore and Japan to conduct clinical trials in Asia

Almac today announced the expansion of its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia.

Read more Medical News

› Verified 1 days ago

• 1
• 2(current)